Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity

Sudhir Chowdhry(Boundless Bio (United States)), John D. Hayes(University of Dundee)

Oncogene

September 10, 2012

10.1038/onc.2012.388

Cited by 629

Related Papers

Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2)

|Cellular and Molecular Gastroenterology and Hepatology|2017|208

Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers

|Pharmacogenetics|1998|143

Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.

|PubMed|1996|128

Enhancing transcription–replication conflict targets ecDNA-positive cancers

|Nature|2024|88

The selective post-translational processing of transcription factor Nrf1 yields distinct isoforms that dictate its ability to differentially regulate gene expression

|Scientific Reports|2015|62